News Roche Holding AG Mexican S.E.

Equities

ROG N

CH0012032048

End-of-day quote Mexican S.E. Other stock markets 18:00:00 2024-06-30 EDT			5-day change	1st Jan Change
5,128 ^MXN	-4.07%		-4.07%	+3.91%

07-01	'HB': Sanofi plans to invest billions in Frankfurt	DP
07-01	ROCHE HOLDINGS AG : Deutsche Bank remains Neutral	ZD

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

'HB': Sanofi plans to invest billions in Frankfurt	07-01	DP
ROCHE HOLDINGS AG : Deutsche Bank remains Neutral	07-01	ZD
BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal	07-01	MT
Swiss Market Index Closes Little Changed Amid Key European Inflation Data	06-28	MT
Roche's Eye Therapy Vabysmo Gets EU Panel's Nod for Additional Indication	06-28	MT
Roche: positive CHMP opinion for Vabysmo in OVR	06-28	CF
Roche: positive CHMP opinion for PiaSky in HPN	06-28	CF
Roche Gets EU Panel's Backing for Rare Blood Disorder Therapy	06-28	MT
Roche's Vabysmo Wins EMA Panel's Backing for Retinal Vein Occlusion Indication	06-28	MT
Roche's Vabysmo Gets CHMP Recommendation for Third Indication Retinal Vein Occlusion	06-28	CI
Roche's Rare Blood Disorder Drug PiaSky Backed for Approval in EU	06-28	MT
Chmp Recommends EU Approval of Roche?S Piasky for People with Pnh, A Rare, Life-Threatening Blood Condition	06-28	CI
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	06-28	RE
Roche: WHO prequalification for HPV testing	06-27	CF
Roche Receives Additional Prequalification Designations for HPV Test	06-27	MT
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval	06-25	MT
Roche: approval of Ocrevus SC in Europe	06-25	CF
Roche Wins EU Nod for Subcutaneous Formula of Multiple Sclerosis Drug Ocrevus	06-25	MT
Roche's Multiple Sclerosis Injection Gets EU Approval	06-25	DJ
Halozyme Therapeutics, Inc. Announces Roche's OCREVUS SC with ENHANZE Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis	06-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am